Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2011 Filed Feb 23, 2011 23:01 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 8 | $46.88 | $375.04 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 138 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:46 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 43,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003263 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,031 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:47 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 50,100 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003265 · edgar.xml · derivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,100 Underlying: Common Shares · 50,100 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,700 on 02/18/2012, 16,700 on 02/18/2013, and 16,700 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:47 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantCommon shares without par value | 35,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003265 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,635 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:47 UTC |
Blaser Brian J.Senior Vice President
|
GrantOption (right to buy) · Derivative | 41,600 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003264 · edgar.xml · derivative · entry 3 Blaser Brian J · CIK 0001492289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,600 Underlying: Common shares · 41,600 shares Expires 2021-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,867 on 02/18/2012, 13,866 on 02/18/2013, and 13,867 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:47 UTC |
Blaser Brian J.Senior Vice President
|
GrantCommon shares without par value | 29,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003264 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,452 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 86,300 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003267 · edgar.xml · derivative · entry 7 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,300 Underlying: Common shares · 86,300 shares Expires 2021-02-17 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,767 on 02/18/2012, 28,766 on 02/18/2013, and 28,767 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:50 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 61,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003267 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,779 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:49 UTC |
Michael Edward L.Executive Vice President
|
GrantOption (right to buy) · Derivative | 55,100 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003266 · edgar.xml · derivative · entry 2 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,100 Underlying: Common Shares · 55,100 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,367 on 02/18/2012, 18,366 on 02/18/2013, and 18,367 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:49 UTC |
Michael Edward L.Executive Vice President
|
GrantCommon shares without par value | 39,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003266 · edgar.xml · nonDerivative · entry 1 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,995 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:51 UTC |
Szela Mary TSenior Vice President
|
GrantOption (right to buy) · Derivative | 31,200 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003269 · edgar.xml · derivative · entry 3 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 Underlying: Common shares · 31,200 shares Expires 2021-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,400 on 02/18/2012, 10,400 on 02/18/2013, and 10,400 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:51 UTC |
Szela Mary TSenior Vice President
|
GrantCommon shares without par value | 22,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003269 · edgar.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,442 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:51 UTC |
Patton Donald V JRSenior Vice President
|
GrantOption (right to buy) · Derivative | 36,800 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003268 · edgar.xml · derivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,800 Underlying: Common shares · 36,800 shares Expires 2021-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,267 on 02/18/2012, 12,266 on 02/18/2013, and 12,267 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:51 UTC |
Patton Donald V JRSenior Vice President
|
GrantCommon shares without par value | 26,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003268 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,519 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:52 UTC |
MAZZO JAMES VSenior Vice President
|
GrantOption (right to buy) · Derivative | 31,200 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003270 · edgar.xml · derivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 Underlying: Common shares · 31,200 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,400 on 02/18/2012, 10,400 on 02/18/2013, and 10,400 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:52 UTC |
MAZZO JAMES VSenior Vice President
|
GrantCommon shares without par value | 22,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003270 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,796 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:54 UTC |
GONZALEZ RICHARD AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 55,100 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003272 · edgar.xml · derivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,100 Underlying: Common shares · 55,100 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,367 on 02/18/2012, 18,366 on 02/18/2013, and 18,367 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:54 UTC |
GONZALEZ RICHARD AExecutive Vice President
|
GrantCommon shares without par value | 39,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003272 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,533 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:53 UTC |
White J. ScottSenior Vice President
|
GrantOption (right to buy) · Derivative | 41,600 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003271 · edgar.xml · derivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,600 Underlying: Common shares · 41,600 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,867 on 02/18/2012, 13,866 on 02/18/2013, and 13,867 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:53 UTC |
White J. ScottSenior Vice President
|
GrantCommon shares without par value | 29,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003271 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,222 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:55 UTC |
ALBAN CARLOSSenior Vice President
|
GrantOption (right to buy) · Derivative | 45,800 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003273 · edgar.xml · derivative · entry 4 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,800 Underlying: Common shares · 45,800 shares Expires 2021-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,267 on 02/18/2012, 15,266 on 02/18/2013, and 15,267 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:55 UTC |
ALBAN CARLOSSenior Vice President
|
GrantCommon shares without par value | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003273 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,273 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:55 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 35,600 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003274 · edgar.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,600 Underlying: Common shares · 35,600 shares Expires 2021-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,867 on 02/18/2012, 11,866 on 02/18/2013, and 11,867 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:55 UTC |
Hance Robert BSenior Vice President
|
GrantCommon shares without par value | 25,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003274 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,698 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:56 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 57,500 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003275 · edgar.xml · derivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Underlying: Common shares · 57,500 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,167 on 02/18/2012, 19,166 on 02/18/2013, and 19,167 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:56 UTC |
Schumacher Laura JExecutive Vice President
|
GrantCommon shares without par value | 40,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003275 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,463 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:57 UTC |
Warmuth Michael JSenior Vice President
|
GrantOption (right to buy) · Derivative | 45,800 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003279 · edgar.xml · derivative · entry 1 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,800 Underlying: Common shares · 45,800 shares Expires 2021-02-17 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,267 on 02/18/2012, 15,266 on 02/18/2013, and 15,267 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:57 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 28,200 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003276 · edgar.xml · derivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,200 Underlying: Common shares · 28,200 shares Expires 2021-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,400 on 02/18/2012, 9,400 on 02/18/2013, and 9,400 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:57 UTC |
LINDER GREG WVice President
|
GrantCommon shares without par value | 20,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003276 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,962 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:58 UTC |
Mason Heather LSenior Vice President
|
GrantOption (right to buy) · Derivative | 31,200 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003281 · edgar.xml · derivative · entry 2 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 Underlying: Common shares · 31,200 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,400 on 02/18/2012, 10,400 on 02/18/2013, and 10,400 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:58 UTC |
Mason Heather LSenior Vice President
|
GrantCommon shares without par value | 22,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003281 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,646 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 294,700 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003282 · edgar.xml · derivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,700 Underlying: Common shares · 294,700 shares Expires 2021-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 98,234 on 02/18/2012, 98,233 on 02/18/2013, and 98,233 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:59 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 209,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003282 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457,916 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:59 UTC |
Landgraf John CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 50,100 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003283 · edgar.xml · derivative · entry 4 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,100 Underlying: Common shares · 50,100 shares Expires 2021-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,700 on 02/18/2012, 16,700 on 02/18/2013, and 16,700 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:59 UTC |
Landgraf John CExecutive Vice President
|
GrantCommon shares without par value | 35,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003283 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,887 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 23:00 UTC |
Forrest A. DavidSenior Vice President
|
GrantOption (right to buy) · Derivative | 41,600 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003284 · edgar.xml · derivative · entry 3 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,600 Underlying: Common shares · 41,600 shares Expires 2021-02-17 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,867 on 02/18/2012, 13,866 on 02/18/2013, and 13,867 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 23:01 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 45,800 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,800 Underlying: Common shares · 45,800 shares Expires 2021-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,267 on 02/18/2012, 15,266 on 02/18/2013, and 15,267 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 23:01 UTC |
Fussell Stephen RSenior Vice President
|
GrantCommon shares without par value | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,071 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2011 Filed Feb 17, 2011 22:01 UTC |
White J. ScottSenior Vice President
|
Tax withholdingCommon shares without par value | 173 | $45.98 | $7,954.54 |
DisclosureSEC source: 0001179110-11-002924 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,622 Read SEC document |
| February 15, 2011 Filed Feb 17, 2011 22:01 UTC |
Forrest A. DavidSenior Vice President
|
Tax withholdingCommon shares without par value | 247 | $45.98 | $11,357.06 |
DisclosureSEC source: 0001179110-11-002925 · edgar.xml · nonDerivative · entry 1 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,407 Read SEC document |
| February 15, 2011 Filed Feb 17, 2011 22:04 UTC |
Blaser Brian J.Senior Vice President
|
SaleCommon shares without par value | 47 | $46.09 | $2,166.23 |
DisclosureSEC source: 0001179110-11-002926 · edgar.xml · nonDerivative · entry 2 Blaser Brian J · CIK 0001492289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,852 Read SEC document |
| February 15, 2011 Filed Feb 17, 2011 22:04 UTC |
Blaser Brian J.Senior Vice President
|
Tax withholdingCommon shares without par value | 167 | $45.98 | $7,678.66 |
DisclosureSEC source: 0001179110-11-002926 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,899 Read SEC document |
| February 14, 2011 Filed Feb 16, 2011 22:00 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 6,177 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001179110-11-002859 · edgar.xml · derivative · entry 3 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,177 shares Expires 2011-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2011 Filed Feb 16, 2011 22:00 UTC |
FULLER H LAURANCEDirector
|
SaleCommon shares without par value | 6,177 | $46.00 | $284,142.00 |
DisclosureSEC source: 0001179110-11-002859 · edgar.xml · nonDerivative · entry 2 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,436 Read SEC document |
| February 14, 2011 Filed Feb 16, 2011 22:00 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionCommon shares without par value | 6,177 | $42.73 | $263,960.51 |
DisclosureSEC source: 0001179110-11-002859 · edgar.xml · nonDerivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 53,202 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · derivative · entry 16 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 53,202 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 2,300 | $45.50 | $104,650.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 11 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,398 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 400 | $45.49 | $18,194.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,698 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 200 | $45.48 | $9,096.50 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,098 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 4,800 | $45.48 | $218,304.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,298 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.